USANA Health Sciences, Inc.
USNA
$19.41
-$0.50-2.51%
NYSE
| 04/04/2026 | 01/03/2026 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Net Income | -20.07% | -139.85% | -161.49% | -7.45% | -43.15% |
| Total Depreciation and Amortization | -4.45% | 74.81% | 72.10% | 68.43% | 101.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.45% | 561.71% | 24.09% | 27.53% | -29.40% |
| Change in Net Operating Assets | -45.94% | -230.38% | -227.18% | 2.78% | 17.35% |
| Cash from Operations | -36.97% | -158.60% | -106.64% | 52.92% | -12.45% |
| Capital Expenditure | 5.64% | -55.11% | -33.31% | -88.21% | 12.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -23.11% | -23.22% |
| Cash from Investing | 32.98% | 100.54% | -36.78% | -169.21% | 4.74% |
| Total Debt Issued | -- | -30.43% | 100.00% | 938.96% | -- |
| Total Debt Repaid | -- | -33,433.33% | -100.00% | -1,566.67% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 84.34% | 24.32% | -26.58% | -49,032.26% | -15.89% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 74.83% | -41.33% | -1,155.13% | -2,753.66% | -21.10% |
| Foreign Exchange rate Adjustments | 24.62% | 128.11% | -96.97% | 326.32% | 118.88% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 306.31% | 107.14% | -118.34% | -794.05% | -0.05% |